IRB Advisor articles from February 2005

IRB Advisor archives from February 2005

Vioxx, NIH crises lead to questions about drug safety and IRBs' role.
February 1, 2005... Vioxx, NIH crises lead to questions about drug safety and IRBs' role But are IRBs responsible for long-term safety of FDA-approved drugs? The revelation that Merck's popular painkiller rofecoxib (Vioxx), as well as other drugs in the...

2005 issues: Stem cell research, noncompliance.
February 1, 2005... 2005 issues: Stem cell research, noncompliance PRIM&R panelist discusses issues on IRB radar  The work of IRBs will not get easier this year, if predictions from panelists at the fall Public Responsibility in Medicine & Research...

IRB application helps educate researchers.
February 1, 2005... IRB application helps educate researchers Submission process made easier A new computerized tool developed at Vanderbilt University in Nashville, TN, provides investigators with information about IRB policies and human subject research...

New web site centralizes multicenter submissions.(IRBNet)
February 1, 2005... New web site centralizes multicenter submissions IRBNet designed to improve communication Developers of a new web site for researchers and IRB administrators hope it will help streamline review of multisite research by centralizing...

Newborn subjects, vulnerable families.(informed consent for neonatal studies)
February 1, 2005... Newborn subjects, vulnerable families IRBs' challenge: Truly informed consent They're among the most vulnerable research subjects - newborn babies, born with problems, spending the first days of their lives in neonatal intensive care...

CE/CME Questions.(continuing medical education )
February 1, 2005... CE/CME Questions For more information on this program, contact customer service at (800) 688-2421; e-mail: customerservice@ahcpub.com. The CE/CME objectives for IRB Advisor are to help physicians, nurses, and other participants be able...